IRON-REPLETE HAEMODIALYSIS PATIENTS DO NOT REQUIRE HIGHER ERYTHROPOIETIN DOSAGES WHEN CONVERTING FROM SUBCUTANEOUS TO INTRAVENOUS ADMINISTRATION. RESULTS OF THE ITALIAN STUDY ON ERYTHROPOIETIN CONVERTING (ISEC) / Pizzarelli, F; David, Salvatore; Sala, P; Icardi, A; Casani, A.. - In: AMERICAN JOURNAL OF KIDNEY DISEASES. - ISSN 0272-6386. - 47:(2006), pp. 1027-1035.

IRON-REPLETE HAEMODIALYSIS PATIENTS DO NOT REQUIRE HIGHER ERYTHROPOIETIN DOSAGES WHEN CONVERTING FROM SUBCUTANEOUS TO INTRAVENOUS ADMINISTRATION. RESULTS OF THE ITALIAN STUDY ON ERYTHROPOIETIN CONVERTING (ISEC).

DAVID, Salvatore;
2006-01-01

2006
IRON-REPLETE HAEMODIALYSIS PATIENTS DO NOT REQUIRE HIGHER ERYTHROPOIETIN DOSAGES WHEN CONVERTING FROM SUBCUTANEOUS TO INTRAVENOUS ADMINISTRATION. RESULTS OF THE ITALIAN STUDY ON ERYTHROPOIETIN CONVERTING (ISEC) / Pizzarelli, F; David, Salvatore; Sala, P; Icardi, A; Casani, A.. - In: AMERICAN JOURNAL OF KIDNEY DISEASES. - ISSN 0272-6386. - 47:(2006), pp. 1027-1035.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/1633422
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? ND
social impact